BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27115149)

  • 1. Polyphenols: a Promising Nutritional Approach to Prevent or Reduce the Progression of Prehypertension.
    Davinelli S; Scapagnini G
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):197-202. PubMed ID: 27115149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive therapy versus alternative therapeutic options for prehypertension: an evidence-based approach.
    Gaddam KK; Ventura H; Lavie CJ
    Future Cardiol; 2012 Jan; 8(1):115-22. PubMed ID: 22185450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutrients and Nutraceuticals for the Management of High Normal Blood Pressure: An Evidence-Based Consensus Document.
    Cicero AFG; Grassi D; Tocci G; Galletti F; Borghi C; Ferri C
    High Blood Press Cardiovasc Prev; 2019 Feb; 26(1):9-25. PubMed ID: 30671873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with prehypertension - do we have enough evidence to treat them?
    Marta M; Zanchetti A; Wong ND; Malyszko J; Rysz J; Banach M
    Curr Vasc Pharmacol; 2014; 12(4):586-97. PubMed ID: 23627984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National prevalence and associated risk factors of hypertension and prehypertension among Vietnamese adults.
    Do HT; Geleijnse JM; Le MB; Kok FJ; Feskens EJ
    Am J Hypertens; 2015 Jan; 28(1):89-97. PubMed ID: 24862960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the effect of DASH diet on blood pressure of patients with type 2 diabetes and prehypertension: Randomized clinical trial.
    Hashemi R; Rahimlou M; Baghdadian S; Manafi M
    Diabetes Metab Syndr; 2019; 13(1):1-4. PubMed ID: 30641678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing the progression of prehypertension to hypertension: role of antihypertensives.
    Fuchs FD; de Mello RB; Fuchs SC
    Curr Hypertens Rep; 2015 Jan; 17(1):505. PubMed ID: 25432897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Safety Evaluation of a Cardiovascular Health Dietary Supplement in Adults with Prehypertension and Stage I Hypertension.
    Ryan JJ; Hanes DA; Corroon J; Taylor J; Bradley R
    J Altern Complement Med; 2019 Feb; 25(2):249-256. PubMed ID: 30222364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of Prehypertension Without Progression to Hypertension.
    Niiranen TJ; Larson MG; McCabe EL; Xanthakis V; Vasan RS; Cheng S
    Circulation; 2017 Sep; 136(13):1262-1264. PubMed ID: 28947482
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of dietary polyphenols in the moderation of the inflammatory response in early stage colorectal cancer.
    Little CH; Combet E; McMillan DC; Horgan PG; Roxburgh CS
    Crit Rev Food Sci Nutr; 2017 Jul; 57(11):2310-2320. PubMed ID: 26066365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of prehypertension in young adults.
    Jun M; Xiang Y
    Saudi Med J; 2020 Mar; 41(3):223-231. PubMed ID: 32114593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of elevated inflammatory and endothelial biomarkers with prehypertension among Mongolians in China.
    Wang G; Wang A; Tong W; Liu Y; Zhang Y
    Hypertens Res; 2011 Apr; 34(4):516-20. PubMed ID: 21179100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prehypertension - time to act.
    Gupta P; Nagaraju SP; Gupta A; Mandya Chikkalingaiah KB
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):223-33. PubMed ID: 22382212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prehypertension--prevalence, health risks, and management strategies.
    Egan BM; Stevens-Fabry S
    Nat Rev Cardiol; 2015 May; 12(5):289-300. PubMed ID: 25687779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano-delivery systems for encapsulation of dietary polyphenols: An experimental approach for neurodegenerative diseases and brain tumors.
    Squillaro T; Cimini A; Peluso G; Giordano A; Melone MAB
    Biochem Pharmacol; 2018 Aug; 154():303-317. PubMed ID: 29803506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prehypertension and the cardiometabolic syndrome: pathological and clinical consequences.
    Duprez D; Toleuova A
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1725-33. PubMed ID: 24215200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prehypertension: the rationale for early drug therapy.
    Fuchs FD
    Cardiovasc Ther; 2010 Dec; 28(6):339-43. PubMed ID: 20553286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of prehypertension: lifestyle and/or medication.
    Collier SR; Landram MJ
    Vasc Health Risk Manag; 2012; 8():613-9. PubMed ID: 23172989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-specific predictors of the prehypertension-to-hypertension progression: community-based cohort of a West-Asian population.
    Bozorgmanesh M; Ghoreishian H; Mohebi R; Azizi F; Hadaegh F
    Eur J Prev Cardiol; 2014 Aug; 21(8):956-63. PubMed ID: 23478742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise capacity and progression from prehypertension to hypertension.
    Faselis C; Doumas M; Kokkinos JP; Panagiotakos D; Kheirbek R; Sheriff HM; Hare K; Papademetriou V; Fletcher R; Kokkinos P
    Hypertension; 2012 Aug; 60(2):333-8. PubMed ID: 22753224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.